It is concluded that EAM-2201 has the prospective to induce in vivo pharmacokinetic drug interactions when co-administered with substrates of CYP2C8, CYP3A4 and UGT1A3, which is evaluated in pooled human liver microsomes. The computed facts are in contrast Along with the available very first basic principle calculations and experimental data, https://eam-220109642.anchor-blog.com/11378233/the-5-second-trick-for-eam2201